| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Crizotinib | Crizotinib-D5 | DVE00431 | View CAS 1395950-84-1 |
| Crizotinib | 2-Keto Crizotinib | VE0013909 | View CAS 1415558-82-5 |
Crizotinib Impurities
| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Crizotinib | Crizotinib-D5 | DVE00431 | View CAS 1395950-84-1 |
| Crizotinib | 2-Keto Crizotinib | VE0013909 | View CAS 1415558-82-5 |
[rfq_list]
| Catalogue No. | DVE00431 |
| CAS No. | 1395950-84-1 |
| Molecular Formula | C21H17D5Cl2FN5O |
| Molecular Weight | 455.37 g/mol |
| Parent drug | Crizotinib |
| IUPAC Name | (R)-3-(1-(2, 6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl-3, 3, 4, 5, 5-d5)-1H-pyrazol-4-yl)pyridin-2-amine |
| Synonyms | N/A |
| Smiles | – |
| References | – |
| Status | In-stock |
| ListName | Crizotinib-D5 |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
